Seeing Is Believing
ARWR is currently covered by 13 analysts with an average price target of $39.66. This is a potential upside of $20.16 (103.38%) from yesterday's end of day stock price of $19.5.
Arrowhead Pharmaceuticals's activity chart (see below) currently has 176 price targets and 175 ratings on display. The stock rating distribution of ARWR is 90.74% BUY and 9.26% HOLD.
Analysts average stock forecasts to be materialized ratio is 66.97% with an average time for these price targets to be met of 252.16 days.
Highest price target for ARWR is $80, Lowest price target is $27, average price target is $39.66.
Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 12-Dec-2024. First documented stock forecast 05-Mar-2014.
Currently out of the existing stock ratings of ARWR, 49 are a BUY (90.74%), 5 are a HOLD (9.26%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$60
$38.15 (174.60%)
$60
8 days ago
(12-Dec-2024)
4/18 (22.22%)
$37.86 (171.00%)
193
Buy
$80
$58.15 (266.13%)
$60
17 days ago
(03-Dec-2024)
0/20 (0%)
$53.66 (203.72%)
Buy
$45
$23.15 (105.95%)
$62
23 days ago
(27-Nov-2024)
22/36 (61.11%)
$21.03 (87.73%)
154
Buy
$42
$20.15 (92.22%)
$50
2 months 24 days ago
(26-Sep-2024)
2/9 (22.22%)
$22.38 (114.07%)
100
Buy
$55
$33.15 (151.72%)
$55
4 months 8 days ago
(12-Aug-2024)
8/15 (53.33%)
$32.06 (139.76%)
135
What is ARWR (Arrowhead Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on ARWR (Arrowhead Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on ARWR (Arrowhead Pharmaceuticals)?
Which analyst is the currently most bullish on ARWR (Arrowhead Pharmaceuticals)?
Which analyst is the currently most reserved on ARWR (Arrowhead Pharmaceuticals)?